Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetic Kidney Disease, Type 2 Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05692388
What this trial is testing

Mixed Methods Study of Health-Related Social Needs in African American Adults With Chronic Kidney Disease and Type 2 Diabetes Mellitus

Who this might be right for
Diabetic Nephropathy Type 2 - UncontrolledDiabetes Mellitus, Type 2Chronic Kidney Diseases
Medical College of Wisconsin 330
Not applicableStudy completedNCT07302464
What this trial is testing

Sodium Glucose Co-Transporter 2 Inhibitors on Estimated Glomerular Filtration Rate in Diabetic Versus Non-Diabetic Chronic Kidney Disease Patients

Who this might be right for
Sodium Glucose Co-Transporter 2 InhibitorsEstimated Glomerular Filtration RateDiabetes+1 more
Ain Shams University 60
Not applicableStudy completedNCT03155087
What this trial is testing

PRKAA2 Genetic Polymorphisms and Its Susceptibility to Chinese Type 2 Diabetes Mellitus and Diabetic Nephropathy

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
People's Hospital of Zhengzhou University 750
Not applicableStudy completedNCT01930136
What this trial is testing

Effects of Caloric Restriction in Obesity and Type 2 Diabetes

Who this might be right for
Type 2 DiabetesObesity
Mario Negri Institute for Pharmacological Research 103
Post-approval studies (Phase 4)Looking for participantsNCT07026539
What this trial is testing

Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease Due to Type 2 Diabetes MellitusCardiovascular Diseases
University of Aarhus 80
Testing effectiveness (Phase 2)Study completedNCT01726816
What this trial is testing

Efficacy and Safety Study of Probucol in Patients With Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
Korea Otsuka Pharmaceutical Co., Ltd. 126
Large-scale testing (Phase 3)Study completedNCT02807974
What this trial is testing

Study of CS-3150 in Hypertensive Patients With Type 2 Diabetes and Albuminuria

Who this might be right for
Hypertension
Daiichi Sankyo Co., Ltd. 51
Not applicableStudy completedNCT02150707
What this trial is testing

The Differential Effects of Diabetes Therapy on Inflammation

Who this might be right for
Diabetic NephropathyType 2 Diabetes
University College Dublin 17
Not applicableEnded earlyNCT00607867
What this trial is testing

LoBAG30 Diet in Patients on Metformin

Who this might be right for
Diabetes MellitusDiet
US Department of Veterans Affairs 20
Large-scale testing (Phase 3)Ended earlyNCT00462202
What this trial is testing

Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong

Who this might be right for
Diabetic Nephropathy
Keryx Biopharmaceuticals 200
Not applicableNot Yet RecruitingNCT07726589
What this trial is testing

The Relationship Between Psychological Well-being, Social Support, and Disease Self-management in Patients With Diabetic Nephropathy

Who this might be right for
Diabetic Kidney Disease (DKD)Type 2 Diabetes
National Taiwan University Hospital 161
Testing effectiveness (Phase 2)Active Not RecruitingNCT06866158
What this trial is testing

Autologous Dendritic Cell as Adjunct Therapy for Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease (DKD)
PT. JES Kasih Nusantara Sejahterah 80
Large-scale testing (Phase 3)Study completedNCT02545049
What this trial is testing

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Bayer 7,352
Not applicableNot Yet RecruitingNCT07773467
What this trial is testing

Systemic Immune-Inflammation Index and Platelet Parameters in Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney DiseaseDiabetic NephropathiesType 2 Diabetes Mellitus+1 more
Assiut University 120
Large-scale testing (Phase 3)Ended earlyNCT00555217
What this trial is testing

VA NEPHRON-D: Diabetes iN Nephropathy Study

Who this might be right for
Kidney DiseaseNephropathyType 2 Diabetes
US Department of Veterans Affairs 1,448
Testing effectiveness (Phase 2)Study completedNCT00464880
What this trial is testing

Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy

Who this might be right for
Diabetes Type 2
Novartis 24
Large-scale testing (Phase 3)Study completedNCT00340678
What this trial is testing

Renoprotection in Early Diabetic Nephropathy in Pima Indians

Who this might be right for
Diabetic Nephropathy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 170
Not applicableUnknownNCT05602532
What this trial is testing

Triglyceride-Glucose Index in Diabetic Nephropathy in Type 2diaberes Mellitus Patients

Who this might be right for
Diabetes Mellitus, Type 2
Assiut University 100
Not applicableStudy completedNCT02864914
What this trial is testing

Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treated With Empagliflozin, Compared to DPP-4 Inhibitors

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 333,580
Testing effectiveness (Phase 2)Active Not RecruitingNCT05507892
What this trial is testing

Renal Mechanism of SGLT2 Inhibition

Who this might be right for
Type 2 DiabetesDiabetic Kidney Disease
University of Colorado, Denver 45
Next Page